logo
Select company
Select metric
82.61%Cash to Assets Ratio
VS
Market
97
Sector
89
Industry
83
History
69
$ 7.81Close
$ 5.48 - $ 16.44 52-Week Range
Ticker Information

Ticker

WVE

Company Name

WAVE LIFE SCIENCES LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

WAVE LIFE SCIENCES LTD - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

WVE - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 252.35M$ 208.48M82.61%
3/31/2025$ 288.34M$ 243.07M84.3%
12/31/2024$ 352.21M$ 302.08M85.77%
9/30/2024$ 358.5M$ 310.95M86.73%
6/30/2024$ 208.82M$ 153.96M73.73%
3/31/2024$ 235.27M$ 180.92M76.9%
12/31/2023$ 274.95M$ 200.35M72.87%
9/30/2023$ 199.92M$ 139.94M70%
6/30/2023$ 229.99M$ 172.97M75.21%
3/31/2023$ 267.27M$ 207.56M77.66%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • WAVE LIFE SCIENCES LTD's latest trailing twelve months (TTM) Cash to Assets stands at 69.78%.
  • Over the past 5 years, WAVE LIFE SCIENCES LTD's average Cash to Assets has been 69.78%.
  • The median Cash to Assets for WAVE LIFE SCIENCES LTD during this period was 71.37%
  • WAVE LIFE SCIENCES LTD reached its highest Cash to Assets over the past 5 years at 86.73%.
  • The lowest Cash to Assets recorded by WAVE LIFE SCIENCES LTD in the same timeframe 36.87%

WAVE LIFE SCIENCES LTD's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
URGN : UROGEN PHARMA LTD 45.03%SPRY : ARS PHARMACEUTICALS INC 16.44%NRIX : NURIX THERAPEUTICS INC 15.2%SNDX : SYNDAX PHARMACEUTICALS INC 18.26%NTLA : INTELLIA THERAPEUTICS INC 17.37%GYRE : GYRE THERAPEUTICS INC 23.91%ZYME : ZYMEWORKS INC 24.06%NAGE : NIAGEN BIOSCIENCE INC 66.07%CRMD : CORMEDIX INC 63.07%ABCL : ABCELLERA BIOLOGICS INC 8.38%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for WAVE LIFE SCIENCES LTD is calculated as follows: CashnEq [ $ 216.36M ] / Assets [ $ 310.06M ]
(=) Cash to Assets [ 69.78% ]

WVE - Cash to Assets Ratio, Last 5 years

36.87%

Minimum

Mar 31, 2022

86.73%

Maximum

Sep 30, 2024

69.78%

Average

71.37%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%